FACTS ABOUT MBL77 REVEALED

Not all people with CLL demand therapy. Inspite of all latest innovations, the iwCLL nonetheless recommends watchful observation for sufferers with asymptomatic condition.86 This advice is based on at least two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104